SCHEMBL4469489

SCHEMBL4469489

Cc1cc(CC2(N)N=C(N)C=C(N3CCN(C)CC3)N2)on1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.38
MMP13 P45452 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4471687 0.89 IGF1R (0.38) IGF1R
SCHEMBL4460700 0.88 IGF1R (0.36) IGF1RMMP13
SCHEMBL4462384 0.86 IGF1R (0.40) IGF1R
SCHEMBL4461041 0.81 IGF1R (0.42) IGF1R
SCHEMBL4466158 0.79 VHL (0.34)
SCHEMBL4464010 0.76 IGF1R (0.40) IGF1R
SCHEMBL4458966 0.70 IGF1R (0.44) IGF1R
SCHEMBL4462239 0.66 IGF1R (0.44) IGF1R
SCHEMBL26952641 0.63 DRD2 (0.45) IGF1R
SCHEMBL27306269 0.61 ALOX15 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO disclosed